Key points are not available for this paper at this time.
Although the use of QT-prolonging medications can predispose to torsades de pointes, there is a relative paucity of information that can help clinicians and patients make optimal informed decisions about how best to minimize the risk of this serious complication.
Al‐Khatib et al. (Tue,) studied this question.